Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.73B |
| 2 |
XYZ
Block Inc
XYZ
|
+$672M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$586M |
| 4 |
Mirion Technologies
MIR
|
+$572M |
| 5 |
Zscaler
ZS
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.21B |
| 2 |
Microsoft
MSFT
|
+$1.05B |
| 3 |
Meta Platforms (Facebook)
META
|
+$685M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$545M |
| 5 |
Tesla
TSLA
|
+$537M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.68% |
| 2 | Consumer Discretionary | 9% |
| 3 | Financials | 7.65% |
| 4 | Healthcare | 7.34% |
| 5 | Communication Services | 5.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
PUT
Credit Acceptance
CACC
$6.1B
| $13.8M | ﹤0.01% |
20,000
-91,800
| -82% | -$59.1M |
|
2452
CALL
Marqeta
MQ
$1.75B
| $13.7M | ﹤0.01% |
+200,000
| New | +$17.9M |
|
2453
Groupon
GRPN
$965M
| $13.7M | ﹤0.01% |
592,998
-512,287
| -46% | -$12M |
|
2454
Emergent Biosolutions
EBS
$266M
| $13.7M | ﹤0.01% |
315,685
-391,936
| -55% | -$17.7M |
|
2455
Amphastar Pharmaceuticals
AMPH
$870M
| $13.7M | ﹤0.01% |
588,823
+13,592
| +2% | +$278K |
|
|
XLNX
2456
PUT
DELISTED
Xilinx Inc
XLNX
| $13.7M | ﹤0.01% |
64,600
| – | – |
|
2457
Kyndryl
KD
$3.12B
| $13.7M | ﹤0.01% |
+756,219
| New | +$16.3M |
|
|
ORAN
2458
DELISTED
Orange
ORAN
| $13.7M | ﹤0.01% |
1,296,425
+374,350
| +41% | +$4.05M |
|
|
CERE
2459
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $13.7M | ﹤0.01% |
421,688
-88,059
| -17% | -$3.11M |
|
2460
Super Micro Computer
SMCI
$19.3B
| $13.7M | ﹤0.01% |
3,110,050
-3,239,190
| -51% | -$13.1M |
|
|
PSAG
2461
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
| $13.7M | ﹤0.01% |
1,406,942
| – | – |
|
|
CPE
2462
DELISTED
Callon Petroleum Company
CPE
| $13.7M | ﹤0.01% |
289,041
+223,904
| +344% | +$12M |
|
2463
Amkor Technology
AMKR
$13.6B
| $13.6M | ﹤0.01% |
549,947
-18,377
| -3% | -$428K |
|
2464
USA Compression Partners
USAC
$3.8B
| $13.6M | ﹤0.01% |
+780,297
| New | +$12.5M |
|
2465
Relay Therapeutics
RLAY
$4.3B
| $13.6M | ﹤0.01% |
443,001
+283,420
| +178% | +$8.96M |
|
2466
iShares Expanded Tech Sector ETF
IGM
$10.6B
| $13.6M | ﹤0.01% |
185,700
+28,992
| +19% | +$2.08M |
|
2467
Ligand Pharmaceuticals
LGND
$6.1B
| $13.6M | ﹤0.01% |
140,865
+44,113
| +46% | +$4.08M |
|
2468
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.39B
| $13.6M | ﹤0.01% |
97,785
+12,927
| +15% | +$1.76M |
|
2469
CALL
Okta
OKTA
$24.8B
| $13.6M | ﹤0.01% |
60,500
+45,500
| +303% | +$10.8M |
|
2470
Element Solutions
ESI
$9.39B
| $13.5M | ﹤0.01% |
558,037
-2,275
| -0.4% | -$53.7K |
|
2471
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$8.71B
| $13.5M | ﹤0.01% |
321,210
-35,265
| -10% | -$1.44M |
|
2472
TransAlta
TAC
$3.97B
| $13.5M | ﹤0.01% |
1,214,218
+237,076
| +24% | +$2.58M |
|
2473
BellRing Brands
BRBR
$1.37B
| $13.5M | ﹤0.01% |
473,055
+258,325
| +120% | +$6.75M |
|
2474
iShares US Consumer Staples ETF
IYK
$1.41B
| $13.5M | ﹤0.01% |
201,618
-35,322
| -15% | -$2.21M |
|
2475
Designer Brands
DBI
$338M
| $13.5M | ﹤0.01% |
946,639
+440,728
| +87% | +$6.31M |
|
Similar funds
Goldman Sachs's Q4 2021 Portfolio in Review
As of Q4 2021, Goldman Sachs held 6,959 positions worth $504B, up 6.8% from $471B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q4 2021 filing shows 774 new, 2,658 increased, 2,316 reduced and 526 closed positions. Its largest new stake was Mirion Technologies: 53,265,743 shares worth $558M. The largest sale was Alibaba, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- Goldman Sachs's largest Q4 2021 buy was Mirion Technologies: 53,265,743 shares worth $558M.
- Goldman Sachs added most to Invesco QQQ Trust in Q4 2021, an estimated $1.73B increase.
- Goldman Sachs's biggest Q4 2021 reduction was Alibaba, cutting an estimated $1.21B.
- Goldman Sachs fully exited PPD, Inc. Common Stock in Q4 2021, selling an estimated $277M.
- Goldman Sachs's ten largest holdings make up 18% of its $504B portfolio in Q4 2021.
- Goldman Sachs opened 774 new positions and closed 526 in Q4 2021.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $504B.
Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.